Katharine Lewis, Piers Blombery, Nagendra Prasad Sungala, Pratyush Giri, Tamara Marconi, Tara Cochrane, Roslyn Francis, Sze-Ting Lee, Chun Kei Kris Ma, Vinay Vanguru, Kate Manos, Colm Keane, Sally Hunter, Melinda Burgess, Sushmitha Kannan, Julia Carlson, Mannu Walia, Belinda Butcher, Chan Cheah. "Pembrolizumab (Pembro) plus R-CHOP is efficacious as first-line therapy for primary mediastinal B-cell lymphoma (PMBL) with high rates of ctdna negativity – interim efficacy analysis of the ALLG-Pacific (NHL35) trial." Blood, 2025. doi:10.1182/blood-2025-1016